Subscribe To
Recursion to participate in upcoming investor conferences
SALT LAKE CITY , Dec. 20, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by ...
December 20, 2022, 7:55 am